90%Confidence
0Views
FDASource
2026-03-03Date
Summary
McKesson faces a Class I recall for UDENYCA due to temperature abuse, indicating potential supply chain quality control failures. This could impact patient safety and regulatory compliance for Accord BioPharma's product distribution.
Actionable: Monitor McKesson's supply chain practices and consider reviewing contracts with Accord BioPharma for compliance risks.
AI Confidence: 90%
Data Points
firmMcKesson
classificationClass I
statusOngoing
distributionNationwide in the USA
productUDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now